Shigeru Toyoda, Masashi Sakuma, Kazuyuki Ishida, Yoshihiro Kushida, Ryoichi Soma, Hidehito Takayama, Kazumi Akimoto, Mari Dezawa, Teruo Inoue. Accumulation of endogenous Muse cells in the myocardium and its pathophysiological role in patients with fulminant myocarditis. Clinical and translational science. 2024. 17. 11. e70067
Makoto Takahashi, Yoshihiro Kushida, Yasumasa Kuroda, Shohei Wakao, Yasuhiro Horibata, Hiroyuki Sugimoto, Mari Dezawa, Yoshikatsu Saiki. Structural reconstruction of mouse acute aortic dissection by intravenously administered human Muse cells without immunosuppression. Communications medicine. 2024. 4. 1. 174-174
Yoshihiro Kushida, Yo Oguma, Kana Abe, Taichi Deguchi, Federico Girolamo Barbera, Noriyuki Nishimura, Kazumichi Fujioka, Sota Iwatani, Mari Dezawa. Human post-implantation blastocyst-like characteristics of Muse cells isolated from human umbilical cord. Cellular and molecular life sciences : CMLS. 2024. 81. 1. 297-297
Masayuki Otani, Yoshihiro Kushida, Yasumasa Kuroda, Shohei Wakao, Yo Oguma, Keisuke Sasaki, Shintaro Katahira, Ryohei Terai, Rie Ryoke, Hiroi Nonaka, et al. New rat model of spinal cord infarction with long-lasting functional disabilities generated by intraspinal injection of endothelin-1. Stroke and Vascular Neurology. 2024. svn-2023
Kaung Htet Nay Win, Yoshihiro Kushida, Keiji Yamana, Sota Iwatani, Makiko Yoshida, Nanako Nino, Cho Yee Mon, Hiroyuki Ohsaki, Shingo Kamoshida, Kazumichi Fujioka, et al. Human Muse cells isolated from preterm- and term-umbilical cord delivered therapeutic effects in rat bleomycin-induced lung injury model without immunosuppressant. Stem cell research & therapy. 2024. 15. 1. 147-147
HUMAN POST-IMPLANTATION BLASTOCYST-LIKE CHARACTERISTICS OF NON-TUMORIGENIC MUSE CELLS ISOLATED FROM HUMAN UMBILICAL CORD
(International Society for Stem Cell Research 2024 2024)
ヒト臍帯由来Muse細胞とヒト初期胚との比較
(第23回日本再生医療学会 2024)
Differentiation potential of Muse cells into trophoblast and primordial germ cell lineages beneficial for obstetrics and reproductive medicine
(2023)
Donor-Muse cell therapy for brain and spinal cord: free from surgical treatment, gene introduction, differentiation induction, HLA-matching and immunosuppressant.
(Gordon Research Conferences 2023)